Shionogi pays $2B to acquire a rare disease startup
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a marketed treatment for two inherited conditions.
Sources
- T2Shionogi pays $2B to acquire a rare disease startupBioPharma Dive / Healthcare Dive / MedTech Dive